1. Home
  2. CTNM vs NRGV Comparison

CTNM vs NRGV Comparison

Compare CTNM & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

SELL

Current Price

$9.57

Market Cap

550.7M

Sector

N/A

ML Signal

SELL

Logo Energy Vault Holdings Inc.

NRGV

Energy Vault Holdings Inc.

SELL

Current Price

$3.75

Market Cap

516.4M

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
CTNM
NRGV
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
550.7M
516.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
CTNM
NRGV
Price
$9.57
$3.75
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
★ $21.43
$6.84
AVG Volume (30 Days)
596.9K
★ 4.6M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
0.46
★ 28.57
EPS
N/A
★ N/A
Revenue
N/A
★ $203,671,000.00
Revenue This Year
N/A
$46.84
Revenue Next Year
N/A
$111.16
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 340.86
52 Week Low
$6.73
$2.46
52 Week High
$17.79
$6.65

Technical Indicators

Market Signals
Indicator
CTNM
NRGV
Relative Strength Index (RSI) 46.25 55.97
Support Level $8.59 $3.32
Resistance Level $13.72 $3.78
Average True Range (ATR) 0.77 0.36
MACD 0.23 0.12
Stochastic Oscillator 42.33 75.02

Price Performance

Historical Comparison
CTNM
NRGV

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a diversified portfolio of energy storage solutions to third parties, including proprietary gravity, battery, and green hydrogen-based technologies, supported by technology-agnostic energy management software and integration capabilities. Geographical presence in the United States, Australia, and other countries. The majority of its revenue comes from Australia.

Share on Social Networks: